メインコンテンツにスキップ - Skip to main content

Genome Clinic

What is Genome?

Do you know how your body supports your daily life?

Our bodies are like a grand story woven together by threads called DNA, the blueprint of life within our cells.

The information read from this DNA is called the genome. It contains significant information related to our constitution, medical conditions, and the effectiveness of medicines. This is why “genomic medicine” is getting popular.

What value does genome provide for human?

Genomic information contains essential information related to our constitution, medical conditions, and the effects of medicines. Genomic medicine is an innovative medical approach that analyzes this "genome information" in detail to prevent, diagnose, and treat diseases. This makes it possible to accurately understand the patient's constitution and disease state and offer optimal treatment for each patient.

What are the specific benefits?

  • 1. Providing optimal treatment for each individual

    Providing optimal treatment for each individual

    You can choose the most effective medicines and treatments according to your biological constitution and medical condition.
    This increases the effectiveness of treatment while minimizing the risk of side effects.

  • 2. Early detection of disease

    Early detection of disease

    Knowing your genetic predisposition in advance allows you to detect diseases early and take appropriate preventive measures.
    It also holds promise for early detection of cancer and early detection of cancer recurrence.

  • 3. Healthcare maintenance support

    Healthcare maintenance support

    By knowing your genomic information, you can obtain guidelines for developing healthier lifestyle habits.


Genome has great potential to make future medical care safer and more effective. At our “genome-based clinic”, we unravel the story of your genes and provide genomic medicine that is optimized for each individual.

Genome Clinic
Outpatient Consultation Hours

Morning: 9:00–12:00 (Registration: 8:00–11:30)/
Afternoon: 13:30–16:30 (Registration: 13:00–16:00)

Ⅰ. Diagnosis and Treatment of Intractable Diseases

PediatricsDiagnosis of Pediatric Intractable Diseases Through Genome Analysis

Achondroplasia, Osteogenesis Imperfecta, Hypophosphatasia, etc.

Center for Promoting Treatment of Intractable Diseases

There are approximately 7,000 rare and intractable diseases, many of which are caused by genetic abnormalities. These diseases are especially prevalent in childhood. Genome-based medicine plays a significant role in treating these conditions. Every year, the number of genetically diagnosable rare and intractable diseases is increasing. For more information about rare and intractable diseases, please consult the Intractable Disease Medical Promotion Center or the pediatrics department.

Mon Tue Wed Thu Fri
Morning - - -
Afternoon - - - -
Keiichi Ozono,MD
Center for Promoting Treatment of Intractable Diseases
Center Director

Keiichi Ozono,MD

Professional Background

  • Former Head/Lead, IRUD Program, Osaka University Hospital
  • Member, Global Gene Variant Interpretation Committee for Hypophosphatasia
  • Professor Emeritus, Osaka University

PediatricsDiagnosis of Pediatric Intractable Diseases Through Genome Analysis

Lysosomal Storage Disorders and Other Neurometabolic Diseases

Center for Promoting Treatment of Intractable Diseases

We specialize in inherited metabolic disorders and have long been involved in the clinical care and research of conditions included in newborn mass screening programs, as well as lysosomal storage disorders. Even within this field alone, there are thought to be more than 100 distinct diseases, and specialized expertise is essential for early diagnosis.

At our hospital, we are preparing to accept requests from medical institutions nationwide for enzyme-based diagnostic testing for lysosomal disorders, and we are also in the process of establishing contracts to provide a range of genetic testing services. Although many of these conditions were once considered rare and intractable diseases, effective disease-modifying and curative therapies have now been developed for an increasing number of disorders, and clinical research and trials continue to advance. Accordingly, we aim to engage proactively in this field.

In addition, our Department of Genetic Medicine provides genetic counseling for a wide range of inherited conditions. If you have any concerns related to genetics, please feel free to consult with us.

Mon Tue Wed thu Fri
Morning - - - -
Afternoon - - - -
Norio Sakai,MD
Center for Promoting Treatment of Intractable Diseases
Deputy Center Director

Norio Sakai,MD

Professional Background

  • Professor Emeritus, Division of Health Sciences, Graduate School of Medicine, Osaka University
  • Osaka University Hospital
  • Former Deputy Director, Department of Genetic Medicine

Neurology Identification and Treatment of Inherited Neurological Disorders Through Genome Analysis

Spinocerebellar Degeneration, Muscular Dystrophy, etc.

Neurology

Diseases of the brain (especially intractable neurological diseases), the most mysterious organ, are said to be closely related to genes (genomes). If you have a family history of neurological disease and are concerned about symptoms, please feel free to consult a neurologist.

Mon Tue Wed Thu Fri
Morning - - - -
Afternoon - - - -
Shizuo Onishi, MD
Neurology
Chief Director

Shizuo Onishi, MD

Professional Background

  • Clinical Professor of Neurology (Medical Education), Kansai Medical University

OtorhinolaryngologyDiagnosis and Treatment of Hearing Loss Through Genome Analysis

Hereditary Hearing Loss, etc.

Otorhinolaryngology

My name is Sakamoto and I am an otorhinolaryngologist. I have been involved in genetic treatment for hearing loss since around 2008 when I was working at Hyogo Prefectural Children's Hospital. As a clinical geneticist, I am currently responsible for the genomic outpatient department at Osaka Public University, where I offer genomic treatment for conditions such as hearing loss and tumors. At our hospital, I also accept consultations for genetic diagnosis of hearing loss. If you have any concerns about genetics in the field of otorhinolaryngology, please feel free to contact us.

Mon Tue Wed Thu Fri
Morning - -
Afternoon - - - - -
Hirokazu Sakamoto, MD
Otorhinolaryngology
Ear Center
Center Director

Hirokazu Sakamoto, MD
Professional Background
  • Project Professor (Endowed Chair), Department of Audiology, Speech and Language Pathology, and Information & Communication Disorders, Graduate School of Medicine, Osaka Metropolitan University
  • Board-Certified Clinical Geneticist (Genetic Counseling), certified by the Japan Society of Human Genetics and the Japanese Society for Genetic Counseling
  • Board-Certified Specialist in Voice and Speech Disorders

Cardiovascular MedicineIdentification and Treatment of Inherited Heart Disease Through Genome Analysis

Brugada Syndrome, Inherited Cardiomyopathies, etc.

Cardiovascular Medicine

In the area of cardiovascular disease, early diagnosis of familial hypercholesterolemia, which causes a high rate of myocardial infarction, hereditary arrhythmia, which can lead to sudden death, and hereditary cardiomyopathy is an essential requirement.
Additionally, people who take medications for prolonged periods for conditions such as high blood pressure or ischemic heart disease can also use drug-responsive genetic testing to check how well a drug works and how likely it is to cause side effects. Please feel free to contact us.

Mon Tue Wed Thu Fri
Morning - - -
Afternoon - - - - -
Yasuyuki Toyama, MD
Cardiovascular Medicine
Chief Director

Yasuyuki Toyama, MD
Professional Background
  • Chief Director, Department of Cardiology, Iseikai International General Hospital

NephrologyAssessing the Risk of Declining Kidney Function Through Genomic Analysis

Chronic Kidney Disease (CKD), Polycystic Kidney Disease, etc.

Nephrology
Nephrology

In chronic kidney disease (CKD), renal function and genetic material in the urine protein are identified as relavant. In the future, research to recruit CKD risk factors and source genetic material is expected to accelerate. Even in polycystic kidney, the most frequent hereditary kidney disease, genome analysis has revealed factors involved in renal functional deterioration, and is expected to contribute to diagnostic treatment. In our department, we would like to respond sequentially according to the necessity.

Mon Tue Wed Thu Fri
Morning - - -
Afternoon - - - - -
Yuki Mori, MD
Nephrology
Staff Physician

Yuki Mori, MD
Professional Background
  • Board-Certified Internist
  • Board-Certified Nephrologist

II. Genetic Counseling

Genetic CounselingGenetic Counseling Consultations

Genetic counseling delivered by a Certified Genetic Counselor®

At our hospital, we provide genetic counseling delivered by a Certified Genetic Counselor®.
For example, patient may have concerns such as:
“Cancer is common in my family, and I’m worried, but it doesn’t feel serious enough to see a doctor,” or “A certain illness runs in my family, and I’m concerned about my own risk, but I’m not sure which department I should consult.”
If you have any concerns, why not start by speaking with a Certified Genetic Counselor®?
We can help you organize your family history, your personal situation, and any questions or worries you may have.
Please feel free to contact us.

Mon Tue Wed Thu Fri
Morning
Afternoon

All services are self-pay. The consultation fee is JPY 2,500 per 15 minutes (tax not included).
Appointments are by reservation only.
Genetic testing is available at an additional cost.

Who This Service May Be Suitable For (Examples)

  • You have a family history of a hereditary condition and would like to explore your own risk.
  • You have been told you may have a hereditary condition and are looking for a medical facility that can provide genetic testing.
  • Your child has a hereditary condition, and you would like to discuss future pregnancy and family planning.
  • You would like to consult about genetic factors before marriage or pregnancy.

Consultation Process

  • Please contact our call center and let us know that you would like to schedule a genetic counseling appointment.
  • A Certified Genetic Counselor® will contact you.
  • We will ask about your concerns and obtain a brief family history.
  • Based on the content of your consultation, the appropriate physician will be assigned and your appointment will be confirmed.
  • On the day of your appointment, please visit our hospital to receive genetic counseling.

III. Diagnosis and Treatment of Dementia

PsychiatryGenome Analysis and Dementia Treatment Selection

Alzheimer’s Disease, etc.

Psychiatry

Alzheimer’s disease is the most common form of dementia among people aged 65 and older, and its symptoms typically progress relatively slowly.
It is a condition in which the accumulation of amyloid-β protein and tau protein in the brain leads to impaired cognitive function.
It is believed that both genetic factors and environmental factors, such as lifestyle, contribute to its development.
If you have concerns—such as a strong family history of dementia—please feel free to consult with us.

Mon Tue Wed Thu Fri
Morning - -
Afternoon - - - - -
Takashi Kudo, MD
Psychiatry
Chief Director

Takashi Kudo, MD
Professional Background
  • Director, Dementia Prevention and Treatment Center
  • Chief Director, Department of Psychiatry
  • Professor Emeritus, Osaka University
  • Specially Appointed Professor, Osaka University

IV. Genomic Testing and Diagnosis

PharmacogenomicsGenomic Consultation on Medication Response and Drug Allergy Predisposition

This is a consultation service for genetic testing to assess “how you respond to medications” and your predisposition to drug allergies.
By taking this test in advance, if you develop an illness in the future, we can tailor medication selection to your individual profile—avoiding medications that are less likely to be effective, and minimizing the risk of side effects or allergic reactions. This enables safer, more appropriate, and optimized pharmacotherapy.
When you visit Iseikai International General Hospital, we will adjust your medications—such as selecting alternative drugs or modifying dosages—based on your test results. Even if you are already receiving drug therapy, this test can provide additional reassurance and support continued treatment with greater confidence.
Through this consultation service, we provide an explanation of the pharmacogenomic test, accept applications, and review the test results with you. If necessary, we will also refer you to the appropriate physician. This service will be launched in spring 2025 as part of the health checkup menu of Human Dock SOPHIA at Iseikai International General Hospital.

For appointments or inquiries, please contact our call center.

Yusuke Tanigawara
Pharmacogenomics Department Director
Yusuke Tanigawara
Professional Background
  • Specially Appointed Deputy Director, Iseikai International General Hospital
  • Graduated from the Faculty of Pharmaceutical Sciences, Kyoto University
  • Former Professor of Clinical Pharmacology, Keio University School of Medicine
  • Professor Emeritus, Keio University

SOPHIA Complete Medical Checkup Center (Ningen Dock)

SOPHIA Comprehensive Health Checkup Center (Ningen Dock)

At Ningen Dock SOPHIA, we have been offering genomic diagnostic services, including our Cancer Genome Checkup Program, since 2023.
A new era has already begun—one in which health checkups cannot be discussed without genomic information.
Please feel free to contact us anytime for more information.

Koshiro Ando, MD
Ningen Dock SOPHIA & Health Checkup Center
Director

Koshiro Ando, MD
Professional Background
  • Director, Ningen Dock SOPHIA & Health Checkup Center, Medical Corporation ISEIKAI
  • Provisional Supervising Physician, Ningen Dock and Health Checkups
  • Board-Certified Surgeon, Japan Surgical Society

Genome Testing at Our Hospital

Cancer Genome Testing

Cancer Genome Testing

This test is designed to identify the type and characteristics of cancer.
With a single blood draw, it can analyze 50 cancer-related genes.
It may also help detect cancers at levels that cannot be identified even through imaging tests.
Our hospital is equipped with in-house genomic analysis systems, and a team of experts conducts the analysis. The results are explained by a board-certified clinical geneticist.
Please note that this test is not covered by insurance and is provided as a self-pay service.

Please note the following important points before undergoing cancer genomic testing:
  • [Incidental Findings] Genetic variants unrelated to cancer—such as those associated with inherited traits or the risk of certain conditions—may be discovered incidentally. In such cases, we will provide a detailed explanation through genetic counseling and share information as requested.
  • [Protection of Personal and Genetic Information] Your genetic information will be managed under strict security controls and handled appropriately in accordance with our privacy policy.
  • [Psychological Impact] Depending on the results, learning unexpected information may cause psychological distress for you and/or your family members.
  • [Relevance to Treatment] The test results may not directly determine your treatment, and even if a treatment is selected based on the results, it may not necessarily be effective.

APOE Genetic Testing

APOE Genetic Testing

APOE has three genetically determined variants (E2, E3, and E4), and carrying the E4 variant is known to be a risk factor for Alzheimer’s disease.
APOE genetic testing can help assess the risk of side effects associated with newer Alzheimer’s disease treatments, such as lecanemab.

It takes approximately 2–3 weeks to receive the test results.
This test is not intended to determine whether you will develop the disease in the future.

Next-Generation Sequencer

Next-Generation Sequencer

This is a genome analysis and diagnostic system designed for cancer patients and individuals undergoing comprehensive health checkups (Ningen Dock).
It enables us to perform genome analysis and genome diagnosis in-house at our facility.

For those interested in genomic medicine

For inquiries, please contact the relevant department using the phone number below.

Medical Corporation ISEIKAI
ISEIKAI International General Hospital

SOPHIA
Complete Medical Checkup Center

  • Service Days: Monday–Saturday
    (Closed on Sundays, national holidays,
    and December 31–January 3)
  • Reception Hours: Monday–Saturday
    8:30–17:00
  • 0570-099166
  • FAX 06-4301-5635
  • sophia@iseikaihp.or.jp